R&D Collaboration With Common Partners And Knowledge Leakage To Rivals: The Role Of Ip Litigation

Sarah Edris; René Belderbos; Victor Gilsing

doi:10.5465/AMBPP.2022.125

R&D Collaboration With Common Partners And Knowledge Leakage To Rivals: The Role Of Ip Litigation

Sarah Edris, René Belderbos, Victor Gilsing

Research output: Chapter in Book/Report/Conference proceeding › Conference article in proceeding › Academic › peer-review

2 Downloads (Pure)

Abstract

We argue that knowledge leakage may occur to rival firms through indirect ties, i.e., if rivals collaborate on R&D with a common partner, but that firms with an aggressive patent litigation strategy may be able to restrict such knowledge spillovers. We expect knowledge leakage to be more prominent, and litigation strategy to be less powerful, when the common partner is a university or public research institution adhering to the open science paradigm, compared with when the common partner is another (non-rival) firm. Patent citation analysis among dyads of leading pharmaceutical firms provides qualified support for these hypotheses.

Original language	English
Title of host publication	82nd Annual Meeting of the Academy of Management 2022: A Hybrid Experience, AOM 2022
Publisher	Academy of Management
Volume	2022
DOIs	https://doi.org/10.5465/AMBPP.2022.125
Publication status	Published - 1 Jan 2022
Event	82nd Annual Meeting of the Academy of Management 2022: A Hybrid Experience, AOM 2022 - Seattle, United States Duration: 5 Aug 2022 → 9 Aug 2022 https://aom.org/events/event-detail/2022/08/05/higher-logic-calendar/the-82nd-annual-meeting-of-the-academy-of-management

Publication series

Series	Academy of Management. Annual Meeting Proceedings
Number	1
Volume	2022
ISSN	2151-6561

Conference

Conference	82nd Annual Meeting of the Academy of Management 2022: A Hybrid Experience, AOM 2022
Abbreviated title	AOM 2022
Country/Territory	United States
City	Seattle
Period	5/08/22 → 9/08/22
Internet address	https://aom.org/events/event-detail/2022/08/05/higher-logic-calendar/the-82nd-annual-meeting-of-the-academy-of-management

Access to Document

10.5465/AMBPP.2022.125

Full TextFinal published version, 1.25 MBLicence: Taverne

Cite this

@inproceedings{caab50876c3642ed86b131020b5c8942,

title = "R&D Collaboration With Common Partners And Knowledge Leakage To Rivals: The Role Of Ip Litigation",

abstract = "We argue that knowledge leakage may occur to rival firms through indirect ties, i.e., if rivals collaborate on R&D with a common partner, but that firms with an aggressive patent litigation strategy may be able to restrict such knowledge spillovers. We expect knowledge leakage to be more prominent, and litigation strategy to be less powerful, when the common partner is a university or public research institution adhering to the open science paradigm, compared with when the common partner is another (non-rival) firm. Patent citation analysis among dyads of leading pharmaceutical firms provides qualified support for these hypotheses.",

author = "Sarah Edris and Ren{\'e} Belderbos and Victor Gilsing",

note = "Publisher Copyright: {\textcopyright} 2022 82nd Annual Meeting of the Academy of Management 2022: A Hybrid Experience, AOM 2022.All rights reserved.; 82nd Annual Meeting of the Academy of Management 2022: A Hybrid Experience, AOM 2022, AOM 2022 ; Conference date: 05-08-2022 Through 09-08-2022",

year = "2022",

month = jan,

day = "1",

doi = "10.5465/AMBPP.2022.125",

language = "English",

volume = "2022",

series = "Academy of Management. Annual Meeting Proceedings",

publisher = "Academy of Management",

number = "1",

booktitle = "82nd Annual Meeting of the Academy of Management 2022: A Hybrid Experience, AOM 2022",

address = "United States",

url = "https://aom.org/events/event-detail/2022/08/05/higher-logic-calendar/the-82nd-annual-meeting-of-the-academy-of-management",

}

Edris, S , Belderbos, R & Gilsing, V 2022, R&D Collaboration With Common Partners And Knowledge Leakage To Rivals: The Role Of Ip Litigation. in 82nd Annual Meeting of the Academy of Management 2022: A Hybrid Experience, AOM 2022. vol. 2022, Academy of Management, Academy of Management. Annual Meeting Proceedings, no. 1, vol. 2022, 82nd Annual Meeting of the Academy of Management 2022: A Hybrid Experience, AOM 2022, Seattle, Washington, United States, 5/08/22. https://doi.org/10.5465/AMBPP.2022.125

R&D Collaboration With Common Partners And Knowledge Leakage To Rivals: The Role Of Ip Litigation. / Edris, Sarah ; Belderbos, René; Gilsing, Victor.
82nd Annual Meeting of the Academy of Management 2022: A Hybrid Experience, AOM 2022. Vol. 2022 Academy of Management, 2022. (Academy of Management. Annual Meeting Proceedings; No. 1, Vol. 2022).

Research output: Chapter in Book/Report/Conference proceeding › Conference article in proceeding › Academic › peer-review

TY - GEN

T1 - R&D Collaboration With Common Partners And Knowledge Leakage To Rivals

T2 - 82nd Annual Meeting of the Academy of Management 2022: A Hybrid Experience, AOM 2022

AU - Edris, Sarah

AU - Belderbos, René

AU - Gilsing, Victor

PY - 2022/1/1

Y1 - 2022/1/1

N2 - We argue that knowledge leakage may occur to rival firms through indirect ties, i.e., if rivals collaborate on R&D with a common partner, but that firms with an aggressive patent litigation strategy may be able to restrict such knowledge spillovers. We expect knowledge leakage to be more prominent, and litigation strategy to be less powerful, when the common partner is a university or public research institution adhering to the open science paradigm, compared with when the common partner is another (non-rival) firm. Patent citation analysis among dyads of leading pharmaceutical firms provides qualified support for these hypotheses.

AB - We argue that knowledge leakage may occur to rival firms through indirect ties, i.e., if rivals collaborate on R&D with a common partner, but that firms with an aggressive patent litigation strategy may be able to restrict such knowledge spillovers. We expect knowledge leakage to be more prominent, and litigation strategy to be less powerful, when the common partner is a university or public research institution adhering to the open science paradigm, compared with when the common partner is another (non-rival) firm. Patent citation analysis among dyads of leading pharmaceutical firms provides qualified support for these hypotheses.

U2 - 10.5465/AMBPP.2022.125

DO - 10.5465/AMBPP.2022.125

M3 - Conference article in proceeding

VL - 2022

T3 - Academy of Management. Annual Meeting Proceedings

BT - 82nd Annual Meeting of the Academy of Management 2022: A Hybrid Experience, AOM 2022

PB - Academy of Management

Y2 - 5 August 2022 through 9 August 2022

ER -